Getting Ozempic completely free is possible through Novo Nordisk’s Patient Assistance Program if you meet specific income and insurance requirements. Other pathways can reduce your cost to as little as $25 per month. The route that works for you depends on your insurance status, income, and the medical reason you need the medication.
Novo Nordisk’s Patient Assistance Program
The most direct path to free Ozempic is through the manufacturer’s own Patient Assistance Program (PAP), run through NovoCare. If approved, you receive the medication at no cost and can renew annually for as long as you continue to qualify. For uninsured patients, each approval lasts 12 months.
To be eligible in 2026, you must be a U.S. citizen or legal resident and fall into one of two categories. If you’re uninsured, your total household income must be at or below 200% of the federal poverty level. For a single person in 2025, that’s roughly $31,000 per year; for a family of four, about $64,000. You also cannot qualify for other government programs like Medicaid or Veterans Affairs benefits.
If you have Medicare, eligibility has recently narrowed. Medicare beneficiaries with Part D prescription drug coverage are no longer eligible to receive Ozempic through the PAP. People with private or commercial insurance are also excluded from this program entirely. The program is specifically designed for those who have the fewest other options.
You can apply through NovoCare’s website or by calling their support line. Your prescribing provider will need to be involved in the application, and you should expect to provide documentation of your income and insurance status.
Savings Cards for Commercial Insurance
If you have private or employer-sponsored insurance that covers Ozempic, the manufacturer offers a savings card that brings your copay down to as little as $25 per month. The card provides up to $100 in monthly savings and is valid for up to 48 months, so it can meaningfully reduce costs over several years of treatment.
This isn’t technically free, but for many people it’s the next best thing. The catch: you must have commercial insurance that already includes Ozempic on its formulary. Government insurance beneficiaries, including those on Medicare, Medicaid, or TRICARE, are not eligible for the savings card.
Getting Your Insurance to Cover Ozempic
Most insurers require prior authorization before they’ll pay for Ozempic, and understanding what they look for can make the difference between approval and denial. Ozempic is FDA-approved specifically for type 2 diabetes, not for weight loss alone, so insurers evaluate coverage based on a diabetes diagnosis.
A typical prior authorization form asks your doctor to document a confirmed type 2 diabetes diagnosis along with blood sugar evidence such as an A1C of 6.5% or higher. Many plans also require “step therapy,” meaning you need to have tried a cheaper first-line medication (usually metformin) for at least three months without adequate results before they’ll approve Ozempic. If metformin didn’t control your blood sugar or you have a medical reason you can’t take it, your doctor can document that as part of the authorization request.
If your initial prior authorization is denied, you have the right to appeal. Your doctor can submit additional clinical documentation supporting why Ozempic is medically necessary for you. Many denials are overturned on appeal when the paperwork includes the specific clinical benchmarks the insurer is looking for.
Medicaid Coverage
If you’re on Medicaid and have type 2 diabetes, your state is required to cover Ozempic. Because the drug is FDA-approved for diabetes, state Medicaid programs cannot exclude it for that use. Your copay on Medicaid is typically very low or zero.
The picture is different if you’re seeking Ozempic (or related GLP-1 drugs) for weight management. Medicaid coverage for obesity treatment is optional, and only 13 state Medicaid programs covered GLP-1 medications for obesity as of January 2026. If you live outside those states and don’t have a diabetes diagnosis, Medicaid likely won’t cover it. For children, however, Medicaid’s early screening and treatment benefit can require coverage when it’s deemed medically necessary regardless of state policy.
Medicare and the GLP-1 Bridge Program
Medicare has historically not covered medications prescribed purely for weight loss. That’s changing partially with the Medicare GLP-1 Bridge, a short-term demonstration program running from July 2026 through December 2027. This program will cover certain GLP-1 drugs for weight management for eligible beneficiaries, but Ozempic is not on the list. The eligible medications are Wegovy, Zepbound, and Foundayo.
If you have Medicare and type 2 diabetes, your Part D plan may already cover Ozempic for that diagnosis. Check your plan’s formulary or call the number on your membership card to confirm. If Ozempic isn’t on your plan’s formulary, your doctor can request a formulary exception.
Clinical Trials
Enrolling in a clinical trial is another way to receive semaglutide (the active ingredient in Ozempic) at no cost. Trials typically provide the study medication, medical monitoring, and lab work for free. Past semaglutide trials have enrolled adults 18 and older with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition like high blood pressure, high cholesterol, or sleep apnea. Most trials also require that you’ve previously tried to lose weight through diet without lasting success.
The tradeoff is that clinical trials involve regular study visits, you may be randomly assigned to a placebo group, and the trial location may not be near you. To find currently recruiting studies, search ClinicalTrials.gov for “semaglutide” and filter results by “Recruiting” status. You can also filter by location to find trials within a reasonable distance.
Avoiding Counterfeit Ozempic
Any offer for free or deeply discounted Ozempic from an online seller, social media ad, or unlicensed pharmacy should raise immediate red flags. The FDA has issued warnings about counterfeit Ozempic pens found in the U.S. drug supply chain. Analysis of seized counterfeits revealed fake pen labels, fake needles with unconfirmed sterility (posing infection risk), and fraudulent patient information inserts. In some cases, the actual contents of the pens could not be verified as genuine semaglutide.
You can spot one known batch of counterfeits by checking the pen label: on fakes with lot number PAR1229, the expiration and lot text appears to the left of the date, while authentic pens place that text above the date and lot number. More broadly, only obtain Ozempic with a valid prescription from a state-licensed pharmacy. If a deal seems too good to be true, particularly from an online source you haven’t used before, it very likely is. Counterfeit medications can be reported directly to the FDA.